{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:02:26Z","timestamp":1779674546371,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF) of Korea.","doi-asserted-by":"crossref","award":["RS-2025-02219039, RS-2024-00452747, RS-2022-NR070224 and RS-2025-02218875"],"award-info":[{"award-number":["RS-2025-02219039, RS-2024-00452747, RS-2022-NR070224 and RS-2025-02218875"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003693","name":"Korea Institute of Science and Technology","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/501100003693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04357-7","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:26:54Z","timestamp":1775780814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repositioning of Ertiprotafib via supramolecular assembly enables biomarker-guided therapy for acute kidney injury"],"prefix":"10.1186","volume":"24","author":[{"given":"Hochung","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeongmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngri","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunbyeol","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Sook","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Won","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Kyung","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangmine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangmeyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoosoo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Kyu","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"1","key":"4357_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","volume":"7","author":"JA Kellum","year":"2021","unstructured":"Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nat reviews Disease primers. 2021;7(1):52.","journal-title":"Nat reviews Disease primers"},{"issue":"9","key":"4357_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/ki.2011.339","volume":"81","author":"K Singbartl","year":"2012","unstructured":"Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012;81(9):819\u201325.","journal-title":"Kidney Int"},{"issue":"4","key":"4357_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrneph.2011.13","volume":"7","author":"R Murugan","year":"2011","unstructured":"Murugan R, Kellum JA. Acute kidney injury: what\u2019s the prognosis? Nat Rev Nephrol. 2011;7(4):209\u201317.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"4357_CR4","doi-asserted-by":"publisher","first-page":"ITC66","DOI":"10.7326\/AITC201711070","volume":"167","author":"AS Levey","year":"2017","unstructured":"Levey AS, James MT. Acute kidney injury. Ann Intern Med. 2017;167(9):ITC66\u201380.","journal-title":"Ann Intern Med"},{"issue":"5","key":"4357_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1681\/ASN.2013070780","volume":"25","author":"GP Kaushal","year":"2014","unstructured":"Kaushal GP, Shah SV. Challenges and advances in the treatment of AKI. J Am Soc Nephrol. 2014;25(5):877\u201383.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"4357_CR6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nrd895","volume":"1","author":"TO Johnson","year":"2002","unstructured":"Johnson TO, Ermolieff J, Jirousek MR. Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discovery. 2002;1(9):696\u2013709.","journal-title":"Nat Rev Drug Discovery"},{"issue":"9\u201310","key":"4357_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.drudis.2007.03.011","volume":"12","author":"S Zhang","year":"2007","unstructured":"Zhang S, Zhang Z-Y. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Discovery Today. 2007;12(9\u201310):373\u201381.","journal-title":"Drug Discovery Today"},{"issue":"6","key":"4357_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41574-024-00965-1","volume":"20","author":"M Delibegovi\u0107","year":"2024","unstructured":"Delibegovi\u0107 M, Dall\u2019Angelo S, Dekeryte R. Protein tyrosine phosphatase 1B in metabolic diseases and drug development. Nat Reviews Endocrinol. 2024;20(6):366\u201378.","journal-title":"Nat Reviews Endocrinol"},{"issue":"11","key":"4357_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrd.2016.151","volume":"15","author":"AK Rines","year":"2016","unstructured":"Rines AK, Sharabi K, Tavares CD, Puigserver P. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes. Nat Rev Drug Discovery. 2016;15(11):786\u2013804.","journal-title":"Nat Rev Drug Discovery"},{"issue":"10","key":"4357_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/aps.2014.80","volume":"35","author":"R-j He","year":"2014","unstructured":"He R-j, Yu Z-h, Zhang R-y, Zhang Z-y. Protein tyrosine phosphatases as potential therapeutic targets. Acta Pharmacol Sin. 2014;35(10):1227\u201346.","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"4357_CR11","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1158\/1078-0432.CCR-16-0934","volume":"23","author":"LR Bollu","year":"2017","unstructured":"Bollu LR, Mazumdar A, Savage MI, Brown PH. Molecular pathways: targeting protein tyrosine phosphatases in cancer. Clin Cancer Res. 2017;23(9):2136\u201342.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4357_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/07853890.2018.1489142","volume":"50","author":"M Yan","year":"2018","unstructured":"Yan M, Shu S, Guo C, Tang C, Dong Z. Endoplasmic reticulum stress in ischemic and nephrotoxic acute kidney injury. Ann Med. 2018;50(5):381\u201390.","journal-title":"Ann Med"},{"issue":"7","key":"4357_CR13","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/biom12070984","volume":"12","author":"N Li","year":"2022","unstructured":"Li N, Lin G, Zhang H, Sun J, Gui M, Liu Y, Li W, Liu J, Tang J. Src family kinases: a potential therapeutic target for acute kidney injury. Biomolecules. 2022;12(7):984.","journal-title":"Biomolecules"},{"key":"4357_CR14","doi-asserted-by":"publisher","first-page":"114041","DOI":"10.1016\/j.jconrel.2025.114041","volume":"385","author":"B Park","year":"2025","unstructured":"Park B, Park D, Jang H, Ko YS, Lee HY, Choi YE, Choi J, Oh SW, Jo S-K, Kim SH, Kim Y, Lee S, Kim K, Kim M-G, Yang Y, Shim MK. Repurposing mesalamine for acute kidney injury through supramolecular assembly. J Controlled Release. 2025;385:114041.","journal-title":"J Controlled Release"},{"key":"4357_CR15","doi-asserted-by":"publisher","first-page":"114177","DOI":"10.1016\/j.addr.2022.114177","volume":"183","author":"M Kyu Shim","year":"2022","unstructured":"Kyu Shim M, Yang S, Sun I-C, Kim K. Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery. Adv Drug Deliv Rev. 2022;183:114177.","journal-title":"Adv Drug Deliv Rev"},{"issue":"52","key":"4357_CR16","doi-asserted-by":"publisher","first-page":"2101460","DOI":"10.1002\/smll.202101460","volume":"17","author":"G Li","year":"2021","unstructured":"Li G, Sun B, Li Y, Luo C, He Z, Sun J. Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery. Small. 2021;17(52):2101460.","journal-title":"Small"},{"issue":"2","key":"4357_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nnano.2014.337","volume":"10","author":"E Mattia","year":"2015","unstructured":"Mattia E, Otto S. Supramolecular systems chemistry. Nat Nanotechnol. 2015;10(2):111\u20139.","journal-title":"Nat Nanotechnol"},{"key":"4357_CR18","doi-asserted-by":"crossref","unstructured":"Maadelat AO, Wehella S, Douvris A, Manturthi S, Burns KD, Gadde S. Nanoparticle-delivered miR-486-5p inhibits H 2 O 2-induced injury in cultured endothelial and kidney tubular epithelial cells. Nanoscale Adv 2026;(8):1213-1227.","DOI":"10.1039\/D5NA00581G"},{"key":"4357_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","volume":"334","author":"Y Huang","year":"2021","unstructured":"Huang Y, Wang J, Jiang K, Chung EJ. Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions. J Controlled Release. 2021;334:127\u201337.","journal-title":"J Controlled Release"},{"issue":"6","key":"4357_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.kint.2025.09.012","volume":"108","author":"H Sheng","year":"2025","unstructured":"Sheng H, Yao Q, Kou L. Is NP-HEV [\u03b1IL21] accumulation in kidney allografts driven by active HEV targeting or passive inflammatory uptake? Kidney Int. 2025;108(6):1189.","journal-title":"Kidney Int"},{"issue":"6","key":"4357_CR21","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.7150\/thno.126217","volume":"16","author":"Y Deng","year":"2026","unstructured":"Deng Y, Liu Z, Zhu X, Wang Y, Feng X, Yang J. Kidney-targeted nanoplatforms: Strategies and applications. Theranostics. 2026;16(6):3011.","journal-title":"Theranostics"},{"issue":"1","key":"4357_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41392-025-02405-6","volume":"10","author":"B Park","year":"2025","unstructured":"Park B, Choi J, Lee J-H, Kim Y, Lee W, Lee A, Sun I-C, Yoon HY, Kim Y, Kim SH. Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapy. Signal Transduct Target Therapy. 2025;10(1):310.","journal-title":"Signal Transduct Target Therapy"},{"key":"4357_CR23","doi-asserted-by":"crossref","unstructured":"Jang Y, Choi J, Park B, Park JY, Lee J-H, Goo J, Shin D, Kim SH, Kim Y, Song HK. Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy. Acta Pharm Sinica B 2025;15(9):4886\u201399.","DOI":"10.1016\/j.apsb.2025.06.028"},{"issue":"38","key":"4357_CR24","doi-asserted-by":"publisher","first-page":"2405475","DOI":"10.1002\/adma.202405475","volume":"36","author":"J Choi","year":"2024","unstructured":"Choi J, Park B, Park JY, Shin D, Lee S, Yoon HY, Kim K, Kim SH, Kim Y, Yang Y. Light-triggered PROTAC nanoassemblies for photodynamic IDO proteolysis in cancer immunotherapy. Adv Mater. 2024;36(38):2405475.","journal-title":"Adv Mater"},{"issue":"25","key":"4357_CR25","doi-asserted-by":"publisher","first-page":"16297","DOI":"10.1021\/acsnano.4c05544","volume":"18","author":"B Park","year":"2024","unstructured":"Park B, Han G, Jin DY, Gil KC, Shin D, Lee J, Park JY, Jang H, Park D, Lee S. Mucoadhesive mesalamine prodrug nanoassemblies to target intestinal macrophages for the treatment of inflammatory bowel disease. ACS Nano. 2024;18(25):16297\u2013311.","journal-title":"ACS Nano"},{"issue":"13","key":"4357_CR26","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","volume":"31","author":"C He","year":"2010","unstructured":"He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657\u201366.","journal-title":"Biomaterials"},{"issue":"9\u201310","key":"4357_CR27","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/smll.201201390","volume":"9","author":"X Duan","year":"2013","unstructured":"Duan X, Li Y. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small. 2013;9(9\u201310):1521\u201332.","journal-title":"Small"},{"issue":"10","key":"4357_CR28","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nnano.2013.181","volume":"8","author":"S Tenzer","year":"2013","unstructured":"Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, Schlenk F, Fischer D, Kiouptsi K, Reinhardt C, Landfester K, Schild H, Maskos M, Knauer SK, Stauber RH. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol. 2013;8(10):772\u201381.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"4357_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41565-018-0344-3","volume":"14","author":"VP Vu","year":"2019","unstructured":"Vu VP, Gifford GB, Chen F, Benasutti H, Wang G, Groman EV, Scheinman R, Saba L, Moghimi SM, Simberg D. Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Nat Nanotechnol. 2019;14(3):260\u20138.","journal-title":"Nat Nanotechnol"},{"key":"4357_CR30","doi-asserted-by":"crossref","unstructured":"Bozzer S, Grimaldi MC, De Maso L, Manfredi M, Toffoli G, Dal Bo M, Sblattero D, Macor P. Stealth-engineered albumin-coated nanoparticles for targeted therapy: effective drug delivery and tumor suppression in xenograft-zebrafish model. Int J Nanomed 2024; 19:13267\u201386.","DOI":"10.2147\/IJN.S476241"},{"key":"4357_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jconrel.2018.11.032","volume":"294","author":"MK Shim","year":"2019","unstructured":"Shim MK, Park J, Yoon HY, Lee S, Um W, Kim J-H, Kang S-W, Seo J-W, Hyun S-W, Park JH, Byun Y, Kwon IC, Kim K. Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy. J Controlled Release. 2019;294:376\u201389.","journal-title":"J Controlled Release"},{"issue":"25","key":"4357_CR32","doi-asserted-by":"publisher","first-page":"16297","DOI":"10.1021\/acsnano.4c05544","volume":"18","author":"B Park","year":"2024","unstructured":"Park B, Han G, Jin DY, Gil KC, Shin D, Lee J, Park JY, Jang H, Park D, Lee S, Kim K, Yang Y, Kim Y, Kim J-S, Kim SH. Shim, Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease. ACS Nano. 2024;18(25):16297\u2013311.","journal-title":"ACS Nano"},{"issue":"3","key":"4357_CR33","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/thno.101358","volume":"15","author":"B Park","year":"2025","unstructured":"Park B, Kim EH, Jang H, Kim Y, Ryu Y, Choi J, Shin D, Lee MC, Yang Y, Kim K, Lee S, Kim SH, Shim MK. Drug repositioning of mesalamine via supramolecular nanoassembly for the treatment of drug-induced acute liver failure. Theranostics. 2025;15(3):1122\u201334.","journal-title":"Theranostics"},{"key":"4357_CR34","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jconrel.2018.11.032","volume":"294","author":"MK Shim","year":"2019","unstructured":"Shim MK, Park J, Yoon HY, Lee S, Um W, Kim J-H, Kang S-W, Seo J-W, Hyun S-W, Park JH. Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy. J Controlled Release. 2019;294:376\u201389.","journal-title":"J Controlled Release"},{"key":"4357_CR35","doi-asserted-by":"publisher","first-page":"120791","DOI":"10.1016\/j.biomaterials.2021.120791","volume":"272","author":"S Yang","year":"2021","unstructured":"Yang S, Shim MK, Kim WJ, Choi J, Nam G-H, Kim J, Kim J, Moon Y, Kim HY, Park J. Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity. Biomaterials. 2021;272:120791.","journal-title":"Biomaterials"},{"issue":"5","key":"4357_CR36","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.7150\/thno.69119","volume":"12","author":"Y Moon","year":"2022","unstructured":"Moon Y, Shim MK, Choi J, Yang S, Kim J, Yun WS, Cho H, Park JY, Kim Y, Seong J-K. Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death. Theranostics. 2022;12(5):1999.","journal-title":"Theranostics"},{"issue":"2","key":"4357_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41581-023-00775-0","volume":"20","author":"S Kishi","year":"2024","unstructured":"Kishi S, Nagasu H, Kidokoro K, Kashihara N. Oxidative stress and the role of redox signalling in chronic kidney disease. Nat Rev Nephrol. 2024;20(2):101\u201319.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"4357_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1039\/C9OB01998G","volume":"18","author":"RA Cerulli","year":"2020","unstructured":"Cerulli RA, Kritzer JA. Phosphotyrosine isosteres: past, present and future. Org Biomol Chem. 2020;18(4):583\u2013605.","journal-title":"Org Biomol Chem"},{"issue":"2","key":"4357_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1517\/13543784.12.2.223","volume":"12","author":"Z-Y Zhang","year":"2003","unstructured":"Zhang Z-Y, Lee S-Y. PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesity. Expert Opin Investig Drugs. 2003;12(2):223\u201333.","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"4357_CR40","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1172\/JCI45161","volume":"121","author":"JV Bonventre","year":"2011","unstructured":"Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Investig. 2011;121(11):4210\u201321.","journal-title":"J Clin Investig"},{"issue":"8","key":"4357_CR41","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1046\/j.1440-1746.2003.03056.x","volume":"18","author":"NC Teoh","year":"2003","unstructured":"Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol. 2003;18(8):891\u2013902.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"4357_CR42","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.canlet.2015.01.020","volume":"359","author":"H Liu","year":"2015","unstructured":"Liu H, Wu Y, Zhu S, Liang W, Wang Z, Wang Y, Lv T, Yao Y, Yuan D, Song Y. PTP1B promotes cell proliferation and metastasis through activating src and ERK1\/2 in non-small cell lung cancer. Cancer Lett. 2015;359(2):218\u201325.","journal-title":"Cancer Lett"},{"key":"4357_CR43","doi-asserted-by":"publisher","first-page":"113668","DOI":"10.1016\/j.jim.2024.113668","volume":"528","author":"Y Li","year":"2024","unstructured":"Li Y, Monte A, Dylla L, Moghimi SM, Simberg D. Validation of dot blot immunoassay for measurement of complement opsonization of nanoparticles. J Immunol Methods. 2024;528:113668.","journal-title":"J Immunol Methods"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04357-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04357-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04357-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:14:55Z","timestamp":1779671695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04357-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4357"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04357-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8283086\/v1","asserted-by":"object"}]},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"481"}}